See more : Baguio Green Group Limited (1397.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Diagnamed Holdings Corp. (DMED.CN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Diagnamed Holdings Corp., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Nova Agritech Limited (NOVAAGRI.NS) Income Statement Analysis – Financial Results
- Chaowei Power Holdings Limited (0951.HK) Income Statement Analysis – Financial Results
- Hangzhou Zhongtai Cryogenic Technology Corporation (300435.SZ) Income Statement Analysis – Financial Results
- ESAB India Limited (ESABINDIA.BO) Income Statement Analysis – Financial Results
- Xero Limited (XROLF) Income Statement Analysis – Financial Results
Diagnamed Holdings Corp. (DMED.CN)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.diagnamed.com
About Diagnamed Holdings Corp.
Diagnamed Holdings Corp. engages in developing a platform of software-based prescription digital therapeutic products for detecting brain age and tremors for neurological disorders. The company is headquartered in Vancouver, Canada.
| Metric | 2023 | 2022 | 2021 |
|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 24.71 | 16.06 |
| Gross Profit | 0.00 | -24.71 | -16.06 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% |
| Research & Development | 514.75K | 562.86K | 201.77K |
| General & Administrative | 652.56K | 572.83K | 481.90K |
| Selling & Marketing | 10.35K | 0.00 | 0.00 |
| SG&A | 662.92K | 572.83K | 481.90K |
| Other Expenses | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 1.18M | 1.14M | 683.67K |
| Cost & Expenses | 1.18M | 1.14M | 683.67K |
| Interest Income | 5.89K | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 1.18M | 1.14M | 683.67K |
| EBITDA | -100.27K | 0.00 | 0.00 |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% |
| Operating Income | -1.18M | -1.14M | 580.48K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -100.27K | 3.26K | -1.26M |
| Income Before Tax | -1.28M | -1.13M | -1.95M |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | -4.39K | 1.26M |
| Net Income | -1.28M | -1.13M | -1.95M |
| Net Income Ratio | 0.00% | 0.00% | 0.00% |
| EPS | -0.02 | -0.01 | -0.03 |
| EPS Diluted | -0.02 | -0.01 | -0.03 |
| Weighted Avg Shares Out | 78.19M | 76.22M | 76.22M |
| Weighted Avg Shares Out (Dil) | 78.19M | 76.22M | 76.22M |
Source: https://incomestatements.info
Category: Stock Reports